NIH-funded research Sbir 1 grant

Using a special system to assess brain injuries in patients

Official title: Using an Inclined Plane System to Triage TBI Patients

Funded at Hemex Health, INC. · NIH-10822698 · Data updated 2026-11-12

This study is testing a new way to help doctors quickly and accurately identify mild traumatic brain injuries using a special system and blood tests, which could be especially helpful in emergency rooms that don’t have advanced equipment.

Quick facts

Grant typeSbir 1 grant
Study typeNIH-funded research
Funding institutionHemex Health, INC.
NIH-funded
Lab location1 site (Portland, UNITED STATES)
Project startSeptember 16, 2024
Project endAugust 31, 2025
Funding year2024
Award (this year)$332,122
NIH project number1R43NS135862-01
Project IDNIH-10822698 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced a recent head injury, particularly those with symptoms of mild traumatic brain injury.

Less likely to help

Patients with severe traumatic brain injuries that are already detectable through standard imaging techniques may not benefit from this research.

What this research studies

This research investigates a new method for triaging patients with traumatic brain injuries (TBI) using an inclined plane system. It aims to improve the accuracy of diagnosing mild TBIs, which are often missed by traditional CT scans. By utilizing newly approved biomarkers found in blood samples, the study seeks to provide a more objective assessment of brain injury severity. This approach could enhance the decision-making process for treatment in emergency settings, especially in areas lacking advanced diagnostic tools.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of mild traumatic brain injuries, improving patient outcomes.

How similar studies have gone: Other research has shown promise in using biomarkers for diagnosing brain injuries, indicating that this approach could be effective.

Where this research is happening

  • Hemex Health, INC.
    Portland, United States
    Active

Researchers

  • Principal investigator: Galen, Peter — Hemex Health, INC.
  • Study coordinator: Galen, Peter

Related research

Other NIH-funded projects on the same topics.

  • Affordable microchip technology for blood testing in sickle cell disease and anemia

    This study is working on a new, affordable device that can quickly test your blood for sickle cell disease and other types of anemia right at your doctor's office, helping you and your healthcare team get important results faster for better care.

    NIH research Hemex Health, INC. · Portland, UNITED STATES · NIH-11042808

  • A new test for measuring how hemoglobin releases oxygen in sickle cell disease.

    This study is working on a quick and easy test that helps people with sickle cell disease check how well their blood can carry oxygen, which could lead to better treatment and care, especially in places where medical resources are limited.

    NIH research Hemex Health, INC. · Portland, UNITED STATES · NIH-10830614

  • A portable device for accurate hemoglobin A1C testing

    This study is working on a small, easy-to-use device called HemeChip that can quickly and affordably check hemoglobin A1C levels for people with diabetes, especially in places where healthcare is hard to reach, so they can better manage their condition.

    NIH research Hemex Health, INC. · Portland, UNITED STATES · NIH-10656550

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.